化学
复制子
嘧啶
核苷
胞嘧啶
尿嘧啶
丙型肝炎病毒
立体化学
病毒
病毒学
生物化学
DNA
生物
质粒
作者
Jeremy L. Clark,Laurent Hollecker,J. Christian Mason,Lieven J. Stuyver,Phillip M. Tharnish,Stefania Lostia,Tamara R. McBrayer,Raymond F. Schinazi,Kyoichi A. Watanabe,Michael J. Otto,Phillip A. Furman,Wojciech J. Stec,Steven E. Patterson,Krzysztof W. Pankiewicz
摘要
The pyrimidine nucleoside beta-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine (1) was designed as a hepatitis C virus RNA-dependent RNA polymerase (HCV RdRp) inhibitor. The title compound was obtained by a DAST fluorination of N(4)-benzoyl-1-(2-methyl-3,5-di-O-benzoyl-beta-d-arabinofuranosyl]cytosine to provide N(4)-benzoyl-1-[2-fluoro-2-methyl-3,5-di-O-benzoyl-beta-d-ribofuranosyl]cytosine. The protected 2'-C-methylcytidine was obtained as a byproduct from the DAST fluorination and allowed for the preparation of two biologically active compounds from a common precursor. Compound 1 and 2'-C-methylcytidine were assayed in a subgenomic HCV replicon assay system and found to be potent and selective inhibitors of HCV replication. Compound 1 shows increased inhibitory activity in the HCV replicon assay compared to 2'-C-methylcytidine and low cellular toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI